Jump Financial, LLC Voyager Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.15 - $10.84 $115,601 - $175,261	16,168 New	16,168 $150,000
Q1 2023 May 03, 2023	BUY	$6.0 - $10.78 $34,902 - $62,707	5,817 Added 55.49%	16,300 $125,000
Q4 2022 Feb 13, 2023	SELL	$4.94 - $6.61 $76,653 - $102,567	-15,517 Reduced 59.68%	10,483 $63,000
Q3 2022 Nov 07, 2022	SELL	$5.57 - $7.47 $54,463 - $73,041	-9,778 Reduced 27.33%	26,000 $154,000
Q2 2022 Aug 09, 2022	SELL	$4.82 - $10.09 $5,634 - $11,795	-1,169 Reduced 3.16%	35,778 $211,000
Q1 2022 May 12, 2022	BUY	$2.75 - $9.44 $50,454 - $173,195	18,347 Added 98.64%	36,947 $281,000
Q4 2021 Feb 10, 2022	BUY	$2.47 - $5.55 $45,942 - $103,230	18,600 New	18,600 $50,000

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.